Movement Disorders Drugs

Random Miscellaneous Quiz

Can you name the Movement Disorders Drugs?

Quiz not verified by Sporcle

 plays        
How to Play
HintAnswer
Use: Most effective drug in tx of Tourette's
P-kinetics: Similar to Pramipexole
Use: prolong ALS survival by months
P-kinetics: Rapid PO absorption, excreted unchanged in urine, gradually increase dose
Tolcapone class
Carbidopa class
SE: May interfere with uptake - Rx metabolizes L-dopa into 3-methyldopa which competes for active transport across the BBB.
SE: HA, nasal congestion, increased arousal, pulmonary infiltrates, ergoline-induced s/s, erythromelagia, vasospasm, & pleural or retroperitoneal fibroses.
SE: Insomnia when taken late in the day
P-kinetics: Start with a small dose
Use: Temporary relief of off-period akinesia in Parkinsons. Also used to tx ED.
MOA: D1 and D2 receptor agonist
Reserpine class
Clonazepam class
SSRI class
P-kinetics: SQ. Rapid onset ~ 10 min. Duration 2 hrs
Use: Enhance & prolong the effects of L-dopa; reduce response fluctuations; lowers necessary dose of L-dopa. ?Antioxidant properties?
SE: GI: anorexia, n/v, constipation, dyspepsia, peptic ulcers, symptoms of reflux esophagitis. CV: postural hypotension & cardiac arrhythmias. Dyskinesias.
SE: May be hepatotoxic - (needs signed pt consent & liver monitoring Q 2 wks x 1 yr)
Biperiden class
MOA: Inhibits the L-dopa --> dopamine conversion by dopa decarboxylase in the periphery (does not cross BBB).
Ropinirole class
Pergolide class
Tetrabenxine class
Apomorphine class
Interactions: Vitamin B6 enhances the extracerebral metabolism of L-dopa. MAOI w/ L-dopa can --> HTNive crisis if given within 2 weeks of each other.
MOA: Not completely known. Inhib effects on glutamate-R, NMDA antag, Inactivation of voltage gated Na+ channels. Interferes w/ intracellular events post excitatory AA-R activation
Procyclidine class
SE: Dyskinesias: chorea, ballismus, athetosis, dystonia, myoclonus, tics, tremors. Behavioral effects: anxiety/ agitation, insomnia/ somnolence, confusion/ delusions/ hallucination
Carbidopa + levidopa (1:10 or 1:4)
Bromocriptine class
MOA: Increases dopamine release & reduces dopamine reuptake into dopaminergic nerve terminals of substantia nigra neurons. Unknown MOA.
HintAnswer
Selegiline class
SE: If adverse effects become too severe withdraw gradually. break for 3-21 days, and reinstate gradually
Use: Huntington's dz pts w/ psychosis or disruptive behavior. Also helpful w/ chorea
MOA: Pure D2 receptor agonist
Use: Similar to Bromocriptine, but more effective. May benefit pts not receiving L-dopa. Aids pt w/ response fluctuations to L-dopa
Olanzapine class
P-kinetics: Start at low dose & gradually increase
Use: Gold standard in Parkinson's dz - most efficacious treatment
Use: depression associated with Huntington's disease
Use: Similar to Pramipexole
P-kinetics: Only 1-3% enters the brain across BBB unaltered. Peak plasma levels 1-2 hrs post PO dose. Plasma t1/2 = 1-2 hrs (pts vary -- dosing 3-4x/day).
Benzotropine class
SE: CV: Increased HR, PVCs, A fib (rare), postural hypotension, HTN (usually in the presence of non-specific MAOI or with large doses).
Use: alleviation of chorea
Use: Can be used as 1st line tx for Parkinson's dz - often in combo w/ Sinemet. Commonly used to tx hyperprolactinemia.
SE: Asthenia, dizziness, GI disorders, & elevation of liver enzymes.
Contraindications: psychotic illness, MI hx, PVD, peptic ulcers
Pramipexole class
Rasagiline class
P-kinetics: Variable absorption from GI, peak plasma levels 1-2 hrs post PO dose. Excreted in bile & feces. Build up dose slowly over 2-3 mo to avoid adverse effects
Levodopa class
Entacapone class
MOA: Central (brain) anti-cholinergic
Contraindications: Prostatic hyperplasia, obstructive GI dz, & angle-closure glaucoma
P-kinetics: 2/3 appears in urine as metabolites within 8 hrs (homovanillic acid - HVA and dihydrocyphenylacetic acid - DOPAC). Best response is in the first few yrs of tx.
Risperidone class
Phenothiazine class
SE: Mental Disturbances: confusion, hallucinations, delusions, other psychiatric reactions.
Use: Reduced response to fluctuations w/ L-dopa. Decreased L-dopa clearance. Decreased dopa decarboxylase --> compensatory increase in COMT.
Use: May improve tremor & rigidity in Parkinsons. Little effect on bradykinesia.
P-kinetics: Well absorbed orally. T1/2 ~ 12 hrs. Hepatic metabolism (cytochrome P450, CYP1A2) -- caution in pts w/ hepatic insufficiency.
MOA: D2 receptor agonist (partial D1 agonist)
HintAnswer
MOA: Somewhat selective MAO-B inhibitors. Retard the breakdown of dopamine
SE: Nausea (pretreat w/ anti-emetic - trimethobenzamide or domiperidone), dyskinesias, drowsiness, sweating, hypotension
TCA class
SE: Other: dry mouth, blurred vision, mydriasis, urinary retention, n/v, constipation, tachycardia, increased IOP.
P-kinetics: Readily absorbed from intestines (depends on rate of gastric emptying and pH -- delayed by food). Some other AAs can compete for transport across the BBB.
P-kinetics: Given PO. Loses effectiveness over time.
Haloperidol class
SE: GI (L-dopa alone): anorexia, n/v (avoid anti-emetics like phenothiazines d/t their extrapyramidal effects -- dopamine antagonist; carbidopa reduces these effects.
Group P-kinetics: Advantages: No enzymatic conversion required, crosses BBB w/o competing for amino acid transporter. No potentially toxic metabolites
SE: Increased L-dopa toxicity (dyskinesias, nausea, & confusion), diarrhea, abd pain, orthostatic hypotension, sleep disturbances, & orange urine.
Fluphenzaine class
MOA: Prevents the metabolism of L-dopa --> 3-O-methyldopa (3OMD) by Catechol-0-methyltransferase
MOA: Preferential affinity for D3 family of receptors
SE: Ergoline-induced toxicity effects unlikely. Postural hypotension, fatigue, somnolence, peripheral edema, nausea, constipation, dyskinesias, & confusion.
Contraindications: psychotic pts, angle closure glaucoma (Increased IOP), active peptic ulcers, hx of melanoma (melanin precursor)
Use: alleviation of chorea if refractory to atypical
Amantadine class
Quetiapine class
SE: CNS: drowsiness, mental slowness, inattention, restless, confusion, agitation, delusions, hallucinations, & mood changes.
Orphenadrine class
Clonidine class
Interactions: Should not be taken w/ meperidine, TCAs, serotonin reuptake inhibitors, or in combo w/ nonspecific MAOIs
P-kinetics: Response can decline over time or stop completely. Start at small dose & escalate as effects diminish. Wearing off rxs. Toxicity concern is supersensitivity develpmnt -
Butyrophenones class
P-kinetics: Only helpful for Huntington's dz chorea at very high doses
P-kinetics: Note: Antidepressant MAOIs are either nonspecific or inhibit MAO-A more specifically (5-HT & NE)
Use: Increases amount of L-dopa able to cross the BBB. Combo with L-dopa allows for L-dopa dose reduction up to 85%.
Riluzole class
Trihexyphenidyl class
Use: Monotherapy for mild Parkinsonism or combo tx for advanced pts. Reduces L-dopa dose & smooths response fluctuations. Putative neuroprotective effects (scavenges free radicals)
Carbamazepine class
MOA: Dopamine precursor able to cross the BBB where it is decarboxylated by dopa decarboxylase to form dopamine.

Friend Scores


  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...

Extras

Created Oct 8, 2011ReportNominate
Tags:disorder, drug, movement